Acorda Therapeutics, Inc. Made Big Gain
Fri, Jul 23, 2021 at 05:33 PM
Acorda Therapeutics, Inc. (ACOR:NASDAQ) soared at $4.73, representing a gain of 24.1%. The stock got featured on our News Catalysts scanner on Thu, Jul 22, 2021 at 04:26 PM in the 'AGREEMENT' category. From Thu, Jul 08, 2021, the stock recorded 30.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About Acorda Therapeutics, Inc. (ACOR:NASDAQ)
Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.
Top 10 Gainers:
- SKYA (SKYA:NASDAQ), 100%
- The New Home Company Inc. (NWHM:NYSE), 82.92%
- Veoneer, Inc. (VNE:NYSE), 56.4%
- NRXP (NRXP:NASDAQ), 50.58%
- Socket Mobile, Inc. (SCKT:NASDAQ), 43.97%
- Xenetic Biosciences, Inc. (XBIO:NASDAQ), 35.48%
- Medigus Ltd. (MDGS:NASDAQ), 28%
- GX Acquisition Corp. (GXGX:NASDAQ), 27.18%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 24.15%
- ATA Creativity Global (AACG:NASDAQ), 24.02%